Family Medicine Doctors in El Centro, CA Accepting Medicare

8 Family Medicine doctors found. Showing 1 - 8

Welim Sonye Azinge, Family Medicine - Adult Medicine Medicare: May Accept Medicare Assignments Practice Location: 2026 N Imperial Ave Ste D, El Centro, CA 92243 Phone: 760-693-5372    Fax: 760-693-5375

Dr. Hossein M Ebneshahidi, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1590 S Imperial Ave, El Centro, CA 92243 Phone: 760-970-8906    Fax: 760-970-4070

Lisa M. Rosa-re, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 852 E Danenberg Dr, El Centro, CA 92243 Phone: 760-352-2257    Fax: 760-352-4579

Mr. Jorge Fernando Robles Sr., MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1501 Ocotillo Dr Ste C, El Centro, CA 92243 Phone: 760-353-6363    Fax: 760-355-9521

Waqar Arshad Khan, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 1600 S Imperial Ave Ste 1, El Centro, CA 92243 Phone: 619-962-9620

Juan C Velazquez, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1590 S Imperial Ave, El Centro, CA 92243 Phone: 760-352-2551    Fax: 888-631-5150

Clara Padron-spence, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1503 N Imperial Ave, 204, El Centro, CA 92243 Phone: 760-339-2802    Fax: 760-339-2829

Tien T Vo, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1590 S Imperial Ave, El Centro, CA 92243 Phone: 760-352-2551    Fax: 888-631-5150

News Archive

AmberGen, SomaLogic enter licensing agreement for photocleavable biotin reagent

SomaLogic, Inc. and AmberGen, Inc. announced today that they have entered into a licensing agreement whereby AmberGen will provide its proprietary photocleavable biotin reagent for the commercial use of SomaLogic's SOMAscan technology platform.

Study finds sleep apnea widely undiagnosed among obese type 2 diabetics

Sleep apnea has long been known to be associated with obesity. But a new study published in the June issue of Diabetes Care finds that the disorder is widely undiagnosed among obese individuals with type 2 diabetes - nearly 87 percent of participants reported symptoms, but were never diagnosed.

DNA-binding protein acts like genetic traffic signal to orchestrate early stage embryonic development

New research by UC San Francisco stem cell biologists has revealed that a DNA-binding protein called Foxd3 acts like a genetic traffic signal, holding that ball of undifferentiated cells in a state of readiness for its great transformation in the third week of development.

New type of silicone gel breast implant

A new type of silicone breast implant, currently available to women who agree to be part of a clinical study, offers breast augmentation and reconstruction patients more natural looking breasts with a low complication rate, according to a recent study in Plastic and Reconstructive Surgery, the official medical journal of the American Society of Plastic Surgeons (ASPS).

FDA approves TachoSil adjunctive hemostatic agent for use in cardiovascular surgery

Baxter International Inc. and Nycomed today announced the U.S. Food and Drug Administration (FDA) approval of TachoSil (Absorbable Fibrin Sealant Patch) for use as an adjunct to hemostasis in cardiovascular surgery. TachoSil is the first and only adjunctive hemostatic agent available in the U.S. that combines a collagen patch with a coating of human coagulation factors.

Read more Medical News

› Verified 1 days ago